| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 01/10/2007 | CN1891268A Chinese medicine preparation for treating cardio-cerebrovascular disease, and its preparing method |
| 01/10/2007 | CN1891266A Chinese medicine oral disintegrating tablet for treating angina pectoris, and its preparing method |
| 01/10/2007 | CN1891265A Ginseng-aconite orally disintegrating tablet and its preparing method |
| 01/10/2007 | CN1891263A Use of medicinal composition containing red paeony root for preparing medicinefor treating chronic blood shortage to brain |
| 01/10/2007 | CN1891256A Red sage root dispersible tablet for treating cornary heart diseae and its preparing method |
| 01/10/2007 | CN1891251A Method for preparing Naoan capsule water-soluble substance |
| 01/10/2007 | CN1891250A Method for preparing Naoan soft capsule water-soluble substance |
| 01/10/2007 | CN1891249A Chinese medicine preparation for treating cardio-cerebrovascular disease and its preparing method |
| 01/10/2007 | CN1891242A Production process for removing polycyclic aromatic hydrocarbons from ginkgo leaf extract |
| 01/10/2007 | CN1891235A Pheretima injection preparation and its preparing method |
| 01/10/2007 | CN1891220A 2-amino-3-(alkyl)-pyrimidone derivatives as gsk3.beta. inhibitors |
| 01/10/2007 | CN1891219A Medicinal composition containing rosuvastatin or pitavastatin and B clan vitamin |
| 01/10/2007 | CN1891218A Ranolazine hydrochloride slow-release preparation and its preparing method |
| 01/10/2007 | CN1891215A Compositions having an activity of ameliorating a reduced higher brain function resulting from organic brain lesions |
| 01/10/2007 | CN1891211A Method for preparing curcumin lyophilized liposome |
| 01/10/2007 | CN1891209A Eplerenone crystalline form exhibiting enhanced dissolution rate |
| 01/10/2007 | CN1294135C Pyrrolopyrimidines as protein kinase inhitibors |
| 01/10/2007 | CN1294134C Cyclohexylphenyl vasopression agonists |
| 01/10/2007 | CN1294133C Imidazo-pyrimidine derivatives as ligands for GABA receptors |
| 01/10/2007 | CN1294117C Amidino compound and salts thereof useful as nitric oxide synahase inhibitors |
| 01/10/2007 | CN1293922C Application of HGF gene |
| 01/10/2007 | CN1293915C Method for reducing calcified plaque buildup and cellular malfunction and for balancing ionic calcium |
| 01/10/2007 | CN1293910C Compound gastrodin injection and its preparation and use |
| 01/10/2007 | CN1293900C Medicine for treating cerebral infarction and preparation method |
| 01/10/2007 | CN1293899C Tengdan capsule for treating hypertension |
| 01/10/2007 | CN1293887C Medicine composition for treating cardiovascular and cerebrovascular diseases, and preparation method thereof |
| 01/10/2007 | CN1293874C Traditional Chinese medicine Monascus purpureus went using Lovastatin salt as main active component and its preparation component |
| 01/10/2007 | CN1293868C Application of alpha cyclo-alanine in the process for preparing medicine to treat cerebrovascular and cardiovascular disease |
| 01/10/2007 | CN1293863C Ibolite fumarate nasal cavity administration preparation |
| 01/09/2007 | US7161012 Processes for preparing amorphous atorvastatin hemi-calcium |
| 01/09/2007 | US7161002 Compounds as antiinflammartory agents, antiproliferation agents and and anticancer agents from cyclodehydration of compounds |
| 01/09/2007 | US7160909 Cyclopenta[b]indole derivatives as sPLA2 inhibitors |
| 01/09/2007 | US7160903 Sulfonylaminocarboxylic acids |
| 01/09/2007 | US7160900 Tetrahydropyridino or piperidino heterocyclic derivatives |
| 01/09/2007 | US7160892 Pyrimidone compounds and pharmaceutical compositions containing the same |
| 01/09/2007 | US7160889 Quinazoline compounds |
| 01/09/2007 | US7160883 Pyrrolo-triazine aniline compounds useful as kinase inhibitors |
| 01/09/2007 | US7160879 Melanin concentrating hormone receptor ligands: substituted 2-(4-benzyl-piperazin-1-ylmethyl)- and 2-(4-benzyl-diazepan-1-ylmethyl)-1H-benzoimidazole analogues |
| 01/09/2007 | US7160874 Phenylalanine derivatives |
| 01/09/2007 | US7160873 Texaphyrin coordination compounds and uses thereof |
| 01/09/2007 | US7160863 Fusion protein contains amino acid sequence with 9 to 13 residues of arginine; antagonist of Nuclear Factor Activated T cell (NFAT); short effectiveness and no side effects or antigenicity; signal sequence, immunosuppressants, biodrugs |
| 01/09/2007 | US7160724 Cells for use in the treatment of nervous system disorders |
| 01/09/2007 | US7160720 Nucleotide sequences coding enzymetic polypeptide for use in the treatment of cardiovascular disorders |
| 01/09/2007 | US7160558 Coating and binding agent for pharmaceutical formulations with improved storage stability |
| 01/09/2007 | US7160541 Modified polypeptides stabilized in a desired conformation and methods for producing same |
| 01/09/2007 | CA2467490C Pharmaceutical compositions of 5,8,14-triazatetracyclo[10.3.1.0(2,11).0(4,9)]-hexadeca-2(11)3,5,7,9-pentaene |
| 01/09/2007 | CA2400801C Treatment of congestive heart failure by pretreated autologous blood |
| 01/09/2007 | CA2375372C Mutual prodrugs of amlodipine and atorvastatin |
| 01/09/2007 | CA2344248C 4-amino substituted-2-substituted-1,2,3,4-tetrahydroquinolines as cetp inhibitors |
| 01/09/2007 | CA2343376C Sustained release ranolazine formulations |
| 01/09/2007 | CA2186844C Use of serotonin antagonists (5ht3) for treating fibromyalgia |
| 01/09/2007 | CA2180296C Treatment of arteriosclerosis and xanthoma |
| 01/09/2007 | CA2176511C Biologically active silicon compounds and their therapeutic and cosmetic applications |
| 01/09/2007 | CA2102780C Bis mono-and bicyclic aryl and heteroaryl compounds which inhibit egf and/or pdgf receptor tyrosine kinase |
| 01/08/2007 | WO2007007686A1 Composition for prevention of occurrence of cardiovascular event |
| 01/04/2007 | WO2007002867A1 Abca1 elevating compounds |
| 01/04/2007 | WO2007002638A1 Anti-marinobufagenin antibodies and methods for their use |
| 01/04/2007 | WO2007002584A1 Linear urea mimics antagonists of p2y1 receptor useful in the treatment of thrombotic conditions |
| 01/04/2007 | WO2007002571A2 Use of an anti c5 complement antibody to treat patients with sickle cell disease |
| 01/04/2007 | WO2007002444A1 Thiol-sensitive positive inotropes |
| 01/04/2007 | WO2007002114A1 1,2-dihydro-spiro(3h-indole-3-4’-piperidine) compounds as modulators of the mas receptor novel |
| 01/04/2007 | WO2007001080A1 Beverage/food and pharmaceutical comprising loquat leaf extract |
| 01/04/2007 | WO2007001066A1 Pharmaceutical preparation containing an angiotensin ii receptor antagonist and a calcium channel blocker |
| 01/04/2007 | WO2007001065A2 Method for the preparation of a wet granulated drug product |
| 01/04/2007 | WO2007000967A1 Remedy for cerebral infarction |
| 01/04/2007 | WO2007000928A1 Remedy and/or preventive for chronic heart failure |
| 01/04/2007 | WO2007000924A1 Pharmaceutical composition comprising substance capable of inhibiting or promoting progranulin activity and screening method for substance capable of inhibiting or promoting progranulin activity |
| 01/04/2007 | WO2007000248A1 Heteroaryl-substituted amides comprising an unsaturated or cyclic linker group, and their use as pharmaceuticals |
| 01/04/2007 | WO2007000246A1 Heteroaryl-substituted amides comprising a saturated linker group, and their use as pharmaceuticals |
| 01/04/2007 | WO2007000241A1 Pyrazolopyridine derivatives as inhibitors of beta-adrenergic receptor kinase 1 |
| 01/04/2007 | WO2007000235A1 6-oxazol-4-ylmethoxy-alkoxymethyl substituted benzoic acid derivatives forming ppar ligands, methods for production and the use thereof in the form of drugs |
| 01/04/2007 | WO2006117660A3 Method for treating cancer, coronary, inflammatory and macular disease, combining the modulation of zinc- and/or copper dependent proteins |
| 01/04/2007 | WO2006110816A3 1h-benzimidazole-4-carboxamides substituted with a quaternary carbon at the 2-position are potent parp inhibitors |
| 01/04/2007 | WO2006072615A3 Triazolophthalazines as pde2-inhibitors |
| 01/04/2007 | WO2006068480A3 Protein hydrolysate enriched in peptides inhibiting dpp-iv and their use |
| 01/04/2007 | WO2006060765A3 Use of a compound that activates a vitamin d receptor for reducing intimal hyperplasia, smooth muscle cell proliferation and restenosis in mammals |
| 01/04/2007 | WO2006047479A3 C-fms kinase inhibitors |
| 01/04/2007 | WO2006010142A3 Mineralocorticoid receptor modulator compounds, processes for their preparation, and their use |
| 01/04/2007 | US20070005124 Endoluminal prosthesis comprising a therapeutic agent |
| 01/04/2007 | US20070004962 Cardiac support device with differential compliance |
| 01/04/2007 | US20070004914 enhance humoral and cell-mediated immune responses to vaccine antigens; 2-deoxy-2-amino- beta -D-glucopyranose (glucosamine) glycosidically linked to an cyclic aminoalkyl (aglycon) group; viricide; immunostimulant; antiischemic agent |
| 01/04/2007 | US20070004807 Methods using phenethanolamine derivatives for treatment of respiratory diseases |
| 01/04/2007 | US20070004790 Nonsedating Alpha-2 Agonists |
| 01/04/2007 | US20070004783 Crystalline forms of amlodipine maleate |
| 01/04/2007 | US20070004771 Preparation of 1,6,7-trisubstituted azabenzimidazoles as kinase inhibitors |
| 01/04/2007 | US20070004764 Urea derivatives containing aromatic or heteroaromatic rings, useful as prophylactic or therapeutic agent for a disease for which angiogenesis inhibition is effective |
| 01/04/2007 | US20070004749 Method of stabilizing lipid-rich plaque and method of preventing rupture thereof |
| 01/04/2007 | US20070004746 Imatinib mesylate; antitumor agent |
| 01/04/2007 | US20070004744 Prophylaxis and/or treatment of portal hypertension |
| 01/04/2007 | US20070004740 phosphodiesterase 4 inhibitors which are naphthalene compounds such as 6,7-Dimethoxy-1-[2-(1,3-dioxocyclohexan-2-yl)pyridin-4-yl]-2,3-bis(hydroxymethyl)naphthalene; asthma or inflammatory diseases |
| 01/04/2007 | US20070004739 Condensed polycyclic compounds |
| 01/04/2007 | US20070004736 Imidazole derivative, process for producing the same, and use |
| 01/04/2007 | US20070004718 Ion channel modulating compounds and uses thereof |
| 01/04/2007 | US20070004716 Carboxylic acid compounds and medicinal compositions containing the same as the active ingredient |
| 01/04/2007 | US20070004713 Therapeutic benimidazole compounds |
| 01/04/2007 | US20070004703 Use of 1-(dialkoxyphenylsulfonyl)-3-(pyrrolidino)-3-(phenyl)indolin-2-one compounds to treat hypertension, cardiovascular disorders, central nervous system disorders, psychological disorders, gastrointestinal disorders; affinity for V1b and V1a receptors of arginine-vasopressin |
| 01/04/2007 | US20070004698 specific activator of retinoic acid receptors subtype beta; 6-[3-adamantan-1-yl-4-(2,2-dimethyl[1,3]dioxoian-4-ylmethoxy)phenyl]naphthalene-2-carboxylic acid; useful in human or veterinary medicine; for body/hair hygiene, treating acne-prone skin, promoting hair regrowth, limiting hair loss, dry skin |
| 01/04/2007 | US20070004687 Use of dipyridamole in combination with acetylsalicylic acid and an angiotensin ll antagonist for stroke prevention |
| 01/04/2007 | US20070004012 Reacting chondroitin disaccharide with a recombinantly produced 2-O sulfatase; using 2-O sulfatase for degrading and analyzing glycosaminoglycans (GAGs) present in a sample |
| 01/04/2007 | US20070003630 Anti-angiogenic compositions and methods of use |